Compare Marqeta Inc (MQ) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marqeta Inc vs Twist Bioscience Corp — how do they compare? Marqeta Inc trades at $17.21 (market cap $1.85B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Twist Bioscience Corp is far larger — about 2.9× Marqeta Inc's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Marqeta Inc nearer its low. Which is the better fit depends on your goals.
| MQ | TWST | |
|---|---|---|
Market Cap | $1.85B | $5.45B |
Sector | Technology | Health |
52-Week High | $27.32 | $102.88 |
52-Week Low | $15.04 | $24.16 |
Enterprise Value | $1.15B | $5.37B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MQ trades at $17.44, down slightly by 0.29% today. The stock shows a bullish technical trend with strong moving average signals, though RSI levels suggest potential overbought conditions. Recent financials reveal revenue growth to $624.88M in 2025, but profitability remains weak with a net margin of -2.23%. The company's expansion into Europe with Expensify and a recent 4:1 reverse stock split are key developments. Analyst consensus is a 'Buy' with a $19.00 price target, indicating modest upside potential.
MQ presents a cautious opportunity with growth initiatives offset by profitability challenges. The stock's high P/E of 439 reflects investor optimism on future earnings, but thin margins and inconsistent quarterly results pose risks. Upside depends on successful execution of European expansion and sustained revenue growth, while downside risks include competitive pressures and failure to achieve profitability. Institutional sentiment is mixed, with 59% of analysts recommending 'Hold'.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marqeta Inc
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
